ARCHIVES

In Brief: Shingleton “Unretires” As Director Of Duke Center; O’Brien Interim Head At USC When Hammond Leave

This article is from The Cancer Letter archive.

Vol. 07 No. 30 | July 24, 1981

Download PDF Visit The Full Archive

Related Articles

Extramural Advisory Board Members Listed

October 20, 1995

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

January 26, 1996

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

GSK Vaccine Prevents Lesions Associated With HPV

July 28, 2006

New Data Support Claims That Costs Are Higher For Protocol Patients

August 31, 1984

European Agency Recommends Transfusions Over ESAs For Cancer Patients With Longer Life Expectancy.

June 27, 2008